Susan Lark, MD Speaks Out Against the Newest Osteoporosis Drug, Reclast
Susan Lark, MD, noted medical researcher and women's health practitioner, has spoken out against the newest prescription osteoporosis medication on the market, Reclast, as well as other oral bisphosphonates such as Boniva, Actonel, and Fosamax. Potomac, MD (PRWEB) Novem...Once-a-Year Drug Helps Counter Steroid-Linked Bone Loss
... reclast injection beat daily pill at restoring bone for pa...sphonate pill for these patients. Specifically, reclast (zoledronic acid) was found to hold off and/or rev... The new study was funded by Novartis, which makes reclast to help fight osteoporosis-linked bone loss in pos...McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008
...1 for Sepracor's Lunesta brand. Regan Campbell Ward - McCann also won 5 Awards of Excellence -- 3 for client Vusion, and 1 each for Novartis' reclast brand and Tysabri. McCann Healthcare Worldwide Singapore won 3 Awards of Excellence: all for Nestle Nutrition. And Caudex Medical wo...Once-a-Year Bone Drug Lowers Fracture Risk
... reclast even caused death rate to fall in older users, stu...often result in severe disability, even death. reclast was approved in August by the U.S. Food and Drug A...han 2,100 men and women were randomized to receive reclast or a placebo within 90 days after surgery for a hi...Anti-osteoporosis Drugs Could Result in Irregular Heart Rhythm, New Study
...it for osteoporosis use. The new study, funded by Novartis, shows that reclast works at least as well as existing drugs in the same class, researchers say...tioned about overestimating the importance of the heart rhythm problem. The reclast study showed little apparent difference in overall cardiac deaths and the o...Anti-osteoporosis Drugs Could Result in Irregular Heart Rhythm, New Study
... it for osteoporosis use. The new study, funded by Novartis, shows that reclast works at least as well as existing drugs in the same class, researchers say...tioned about overestimating the importance of the heart rhythm problem. The reclast study showed little apparent difference in overall cardiac deaths and the o...Once-yearly Reclast Significantly Reduced Bone Fractures in Women with Postmenopausal Osteoporosis
- Study of over 7,700 women published today shows reduction of 70 percent in spine fractures and 41 percent in hip fractures EAST HANOVER, N.J., May 02, 2007 /PRNewswire/ -- A once-yearly treatment of Reclast(R) (zoledronic acid) Injection significantly reduced the incidence of all types of osteop...